BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 7552989)

  • 1. Chemotherapy resistance to taxol in clonogenic progenitor cells following transduction of CD34 selected marrow and peripheral blood cells with a retrovirus that contains the MDR-1 chemotherapy resistance gene.
    Hanania EG; Fu S; Zu Z; Hegewisch-Becker S; Korbling M; Hester J; Durett A; Andreeff M; Mechetner E; Holzmayer T
    Gene Ther; 1995 Jun; 2(4):285-94. PubMed ID: 7552989
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Drug-selected co-expression of P-glycoprotein and gp91 in vivo from an MDR1-bicistronic retrovirus vector Ha-MDR-IRES-gp91.
    Sugimoto Y; Tsukahara S; Sato S; Suzuki M; Nunoi H; Malech HL; Gottesman MM; Tsuruo T
    J Gene Med; 2003 May; 5(5):366-76. PubMed ID: 12731085
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Engineered stromal layers and continuous flow culture enhance multidrug resistance gene transfer in hematopoietic progenitors.
    Bertolini F; Battaglia M; Corsini C; Lazzari L; Soligo D; Zibera C; Thalmeier K
    Cancer Res; 1996 Jun; 56(11):2566-72. PubMed ID: 8653699
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Resistance to taxol chemotherapy produced in mouse marrow cells by safety-modified retroviruses containing a human MDR-1 transcription unit.
    Hanania EG; Fu S; Roninson I; Zu Z; Deisseroth AB
    Gene Ther; 1995 Jun; 2(4):279-84. PubMed ID: 7552988
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Retroviral transfer and expression of the human multiple drug resistance (MDR) gene in peripheral blood progenitor cells.
    Ward M; Pioli P; Ayello J; Reiss R; Urzi G; Richardson C; Hesdorffer C; Bank A
    Clin Cancer Res; 1996 May; 2(5):873-6. PubMed ID: 9816243
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Paclitaxel chemotherapy after autologous stem-cell transplantation and engraftment of hematopoietic cells transduced with a retrovirus containing the multidrug resistance complementary DNA (MDR1) in metastatic breast cancer patients.
    Cowan KH; Moscow JA; Huang H; Zujewski JA; O'Shaughnessy J; Sorrentino B; Hines K; Carter C; Schneider E; Cusack G; Noone M; Dunbar C; Steinberg S; Wilson W; Goldspiel B; Read EJ; Leitman SF; McDonagh K; Chow C; Abati A; Chiang Y; Chang YN; Gottesman MM; Pastan I; Nienhuis A
    Clin Cancer Res; 1999 Jul; 5(7):1619-28. PubMed ID: 10430060
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A bicistronic retroviral vector to introduce drug resistance genes into human umbilical cord blood CD34+ cells to improve combination chemotherapy tolerance.
    Wang J; Chen Z; Xia X; Lu D; Xue J; Ruan C
    Chin Med J (Engl); 2001 Jan; 114(1):25-9. PubMed ID: 11779430
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative analysis of retroviral-mediated gene transduction into CD34+ cord blood hematopoietic progenitors in the presence and absence of growth factors.
    Shi YJ; Shen RN; Lu L; Broxmeyer HE
    Blood Cells; 1994; 20(2-3):517-24. PubMed ID: 7538354
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic modification of hematopoietic progenitor cells for combined resistance to 4-hydroperoxycyclophosphamide, vincristine, and daunorubicin.
    Wang JS; Fang Q; Sun DJ; Chen J; Zhou XL; Lin GW; Lu HZ; Fei J
    Acta Pharmacol Sin; 2001 Oct; 22(10):949-55. PubMed ID: 11749781
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transduction of CD34-enriched human peripheral and umbilical cord blood progenitors using a retroviral vector with the Fanconi anemia group C gene.
    Walsh CE; Mann MM; Emmons RV; Wang S; Liu JM
    J Investig Med; 1995 Aug; 43(4):379-85. PubMed ID: 7552587
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serial transplantation shows that early hematopoietic precursor cells are transduced by MDR-1 retroviral vector in a mouse gene therapy model.
    Hanania EG; Deisseroth AB
    Cancer Gene Ther; 1994 Mar; 1(1):21-5. PubMed ID: 7621234
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Methotrexate selection of long-term culture initiating cells following transduction of CD34(+) cells with a retrovirus containing a mutated human dihydrofolate reductase gene.
    Takebe N; Xu LC; MacKenzie KL; Bertino JR; Moore MA
    Cancer Gene Ther; 2002 Mar; 9(3):308-20. PubMed ID: 11896448
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correction of the enzyme deficiency in hematopoietic cells of Gaucher patients using a clinically acceptable retroviral supernatant transduction protocol.
    Xu L; Stahl SK; Dave HP; Schiffmann R; Correll PH; Kessler S; Karlsson S
    Exp Hematol; 1994 Feb; 22(2):223-30. PubMed ID: 8299741
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sustained retroviral gene marking and expression in lymphoid and myeloid cells derived from transduced hematopoietic progenitor cells.
    Plavec I; Voytovich A; Moss K; Webster D; Hanley MB; Escaich S; Ho KE; Böhnlein E; DiGiusto DL
    Gene Ther; 1996 Aug; 3(8):717-24. PubMed ID: 8854097
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adenovirus and retrovirus mediated interferon alpha gene transfer into CD34+ cells maintains regeneration capacity and enhances adhesion molecules in K562 cells.
    Seiter K; Kancherla R; Yang L; Quan S; Farley TJ; Abraham NG; Ahmed T
    J Investig Med; 1999 Sep; 47(8):414-24. PubMed ID: 10510594
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Retroviral coexpression of two different types of drug resistance genes to protect normal cells from combination chemotherapy.
    Suzuki M; Sugimoto Y; Tsukahara S; Okochi E; Gottesman MM; Tsuruo T
    Clin Cancer Res; 1997 Jun; 3(6):947-54. PubMed ID: 9815770
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased gene transfer into human CD34+ progenitor cells using retroviral vectors produced by a canine packaging cell line.
    Bauer G; Sauter S; Ibanez C; Rice CR; Valdez P; Jolly D; Kohn DB
    Biol Blood Marrow Transplant; 1998; 4(3):119-27. PubMed ID: 9923409
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chemoprotection effect of multidrug resistance 1 (MDR1) gene transfer to hematopoietic progenitor cells and engrafted in mice with cancer allows intensified chemotherapy.
    Guo C; Jin X
    Cancer Invest; 2006 Nov; 24(7):659-68. PubMed ID: 17118775
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cell-cycle kinetics and VSV-G pseudotyped retrovirus-mediated gene transfer in blood-derived CD34+ cells.
    Agrawal YP; Agrawal RS; Sinclair AM; Young D; Maruyama M; Levine F; Ho AD
    Exp Hematol; 1996 May; 24(6):738-47. PubMed ID: 8635530
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 5-Fluorouracil-resistant CD34+ cell population from peripheral blood of CML patients contains BCR-ABL-negative progenitor cells.
    Jazwiec B; Mahon FX; Pigneux A; Pigeonnier V; Reiffers J
    Exp Hematol; 1995 Dec; 23(14):1509-14. PubMed ID: 8542939
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.